OneDigital Investment Advisors LLC Has $282,000 Holdings in Humana Inc. (NYSE:HUM)

OneDigital Investment Advisors LLC cut its position in shares of Humana Inc. (NYSE:HUM) by 4.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,113 shares of the insurance provider’s stock after selling 51 shares during the quarter. OneDigital Investment Advisors LLC’s holdings in Humana were worth $282,000 at the end of the most recent reporting period.

Other large investors have also bought and sold shares of the company. FPC Investment Advisory Inc. acquired a new stake in Humana in the fourth quarter worth $27,000. Centricity Wealth Management LLC acquired a new stake in Humana in the fourth quarter worth $30,000. LFA Lugano Financial Advisors SA grew its holdings in Humana by 56.3% in the fourth quarter. LFA Lugano Financial Advisors SA now owns 125 shares of the insurance provider’s stock worth $32,000 after purchasing an additional 45 shares during the period. OFI Invest Asset Management acquired a new stake in Humana in the fourth quarter worth $33,000. Finally, Transce3nd LLC acquired a new stake in Humana in the fourth quarter worth $38,000. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of equities research analysts have commented on the stock. JPMorgan Chase & Co. reduced their price target on shares of Humana from $257.00 to $256.00 and set a “neutral” rating for the company in a report on Tuesday, February 18th. Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $290.00 price objective on shares of Humana in a research note on Wednesday, February 12th. Piper Sandler raised their price objective on shares of Humana from $270.00 to $288.00 and gave the company a “neutral” rating in a research note on Wednesday, January 15th. StockNews.com raised shares of Humana from a “hold” rating to a “buy” rating in a research note on Monday, April 7th. Finally, Truist Financial raised their price objective on shares of Humana from $290.00 to $325.00 and gave the company a “hold” rating in a research note on Friday, April 11th. Seventeen analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. According to MarketBeat, Humana presently has a consensus rating of “Hold” and an average target price of $284.90.

Humana Price Performance

Humana stock opened at $263.08 on Tuesday. Humana Inc. has a 12 month low of $213.31 and a 12 month high of $406.46. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.68. The business’s 50 day simple moving average is $266.31 and its 200 day simple moving average is $270.84. The company has a market cap of $31.75 billion, a price-to-earnings ratio of 26.44, a PEG ratio of 2.05 and a beta of 0.62.

Humana (NYSE:HUM) last posted its quarterly earnings data on Tuesday, February 11th. The insurance provider reported ($2.16) EPS for the quarter, beating the consensus estimate of ($2.26) by $0.10. Humana had a return on equity of 11.70% and a net margin of 1.02%. Sell-side analysts forecast that Humana Inc. will post 16.47 EPS for the current year.

Humana Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Shareholders of record on Friday, June 27th will be given a dividend of $0.885 per share. The ex-dividend date of this dividend is Friday, June 27th. This represents a $3.54 annualized dividend and a dividend yield of 1.35%. Humana’s dividend payout ratio is currently 35.58%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.